These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4423671)

  • 21. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
    Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S
    Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel quinoxaline derivatives and its cytotoxic activities.
    Tanimori S; Nishimura T; Kirihata M
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4119-21. PubMed ID: 19539470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants.
    Wagle S; Adhikari AV; Kumari NS
    Eur J Med Chem; 2009 Mar; 44(3):1135-43. PubMed ID: 18672315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Search for radioprotective agents in the USA].
    Vladimirov VG; Dzharak'ian TK
    Voen Med Zh; 1974 Jun; (6):86-8. PubMed ID: 4617960
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity.
    Budakoti A; Bhat AR; Azam A
    Eur J Med Chem; 2009 Mar; 44(3):1317-25. PubMed ID: 18378360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potential virostatics. Part 3: NMR Studies in quinoxalines and s-triazolo (4,3-a) quinoxalines (author's transl)].
    Schleinitz KD; Westphal G; Köppel H; Wasicki H
    Pharmazie; 1980 Feb; 35(2):84-6. PubMed ID: 7384188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of AET. VI. The protection of proteins against ionizing radiation by GED.
    Kollmann G; Shapiro B
    Radiat Res; 1966 Mar; 27(3):474-86. PubMed ID: 5931439
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines.
    Khan SA; Saleem K; Khan Z
    Eur J Med Chem; 2007 Jan; 42(1):103-8. PubMed ID: 16997429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles.
    Cressier D; Prouillac C; Hernandez P; Amourette C; Diserbo M; Lion C; Rima G
    Bioorg Med Chem; 2009 Jul; 17(14):5275-84. PubMed ID: 19502068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis and bio-activity of coumarin derivatives and studies on its relationships between activity and lipophilicity].
    Wu K; Tong ZS; Dai CS; Li L; Zheng SX
    Yao Xue Xue Bao; 1993; 28(4):266-72. PubMed ID: 8213169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic disulfides. 3. (--)-(S)-1,2-Diethiepan-4-amine and related compounds.
    Herbrandson HF; Wood RH
    J Med Chem; 1969 Jul; 12(4):620-4. PubMed ID: 5793151
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic disulfides. II. 1,2-Dithiepan-5-amine.
    Herbrandson HF; Wood RH
    J Med Chem; 1969 Jul; 12(4):617-20. PubMed ID: 5793150
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
    Habib NS; el-Hawash SA
    Pharmazie; 1997 Aug; 52(8):594-8. PubMed ID: 9292917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on quinoxaline derivatives. Synthesis of quinoxalylamino-1,3-diazacycloalkanes with potential hypotensive activity.
    Foks H; Wisterowicz K; Nasal A; Damasiewicz B; Radwańska A
    Acta Pol Pharm; 1999; 56(3):201-6. PubMed ID: 10635359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
    Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
    Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contributions to the radioprotective effect of nitriles.
    Hernádi F; Nagy Z; Kovács P; Dézsi Z; Vályi-Nagy T
    Acta Biol Acad Sci Hung; 1968; 19(3):257-67. PubMed ID: 4883141
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
    Székelyhidi Z; Pató J; Wáczek F; Bánhegyi P; Hegymegi-Barakonyi B; Erös D; Mészáros G; Hollósy F; Hafenbradl D; Obert S; Klebl B; Kéri G; Orfi L
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3241-6. PubMed ID: 15925511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Mercaptoacetamidine and derivatives as antiradiation agents.
    Westland RD; Merz MM; Alexander SM; Newton LS; Bauer L; Conway TT; Barton JM; Khullar KK; Devdhar PB; Grenan MM
    J Med Chem; 1972 Dec; 15(12):1313-21. PubMed ID: 4635980
    [No Abstract]   [Full Text] [Related]  

  • 40. Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents.
    Glazer EA; Chappel LR
    J Med Chem; 1982 Jul; 25(7):766-9. PubMed ID: 7108893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.